Haematological biomarkers of pathological response on neo-adjuvant chemo-immunotherapy treatment for resectable stage IIIA non-small cell lung cancer (NSCLC) patients.

被引：0
|
作者：
Laza Briviesca, Raquel
Cruz Bermudez, Alberto
Barquin, Miguel
Nadal, Ernest
Insa, Amelia
Garcia-Campelo, Rosario
De Dios Alvarez, Noemi
Domine, Manuel
Massuti, Bartomeu
Majem, Margarita
Rodriguez-Abreu, Delvys
Martinez Marti, Alex
Cobo, Manuel
Lopez-Vivanco, Guillermo
del Barco, Elvira
Bernabe, Reyes
Vinolas, Nuria
Barneto, Isidoro
Viteri, Santiago
Provencio-Pulla, Mariano
机构：
[1] Hosp Univ Puerta De Hierro Majadahonda, Inst Invest Sanitaria Puerta De Hierro Segovia Ar, Madrid, Sudan
[2] Hosp Univ Puerta de Hierro, Majadahonda, Spain
[3] Inst Catala Oncol, Barcelona, Spain
[4] Hosp Clin Univ Valencia, Valencia, Spain
[5] Univ Hosp A Coruna, Coruna, Spain
[6] Complejo Hosp Univ Vigo, Vigo, Spain
[7] Univ Hosp Fdn Jimenez Diaz, Dept Oncol, Madrid, Spain
[8] Univ Hosp Fdn Jimenez Diaz, Translat Oncol Div, Madrid, Spain
[9] Alicante Univ Hosp ISABIAL, Alicante, Spain
[10] Hosp Santa Creu & Sant Pau, Barcelona, Spain
[11] Hosp Univ Insular Gran Canaria, Las Palmas Gran Canaria, Spain
[12] Vall dHebron Univ Hosp, Vall dHebron Inst Oncol VHIO, Barcelona, Spain
[13] Hosp Reg Univ Malaga, Malaga, Spain
[14] Hosp Cruces, Dept Med Oncol, Baracaldo, Spain
[15] Salamanca Univ Hosp, Dept Med Oncol, Salamanca, Spain
[16] Hosp Valme, Seville, Spain
[17] Hosp Clin Barcelona, Barcelona, Spain
[18] Hosp Reina Sofia, Cordoba, Spain
[19] Pangaea Biotech, Clin Unit, Barcelona, Spain
[20] Hosp Univ Puerta de Hierro, Madrid, Spain
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e20026
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Biomarkers of Pathological Response on Neo-Adjuvant Chemo-Immunotherapy Treatment for Resectable Stage IIIA NSCLC Patients
    Laza-Briviesca, R.
    Cruz-Bermudez, A.
    Casarrubios, M.
    Nadal, E.
    Insa, A.
    Garcia Campelo, R.
    De Dios Alvarez, N.
    Domine, M.
    Majem, M.
    Rodriguez-Abreu, D.
    Calvo De Juan, V.
    Martinez-Marti, A.
    De Castro Carpeno, J.
    Cobo, M.
    Lopez-Vivanco, G.
    Del Barco, E.
    Bernabe, R.
    Vinolas, N.
    Barneto, I.
    Viteri, S.
    Massuti, B.
    Provencio, M.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S711 - S711
  • [2] Immune cell biomarkers on neo-adjuvant chemo-immunotherapy treatment for resectable stage IIIA NSCLC patients
    Laza-Briviesca, R.
    Cruz-Bermudez, A.
    Casarrubios, M.
    Nadal, E.
    Insa Molla, M. A.
    Garcia-Campelo, M-R.
    Huidobro, G.
    Domine Gomez, M.
    Majem Tarruella, M.
    Rodriguez Abreu, D.
    Martinez-Marti, A.
    De Castro Carpeno, J.
    Cobo Dols, M.
    Lopez Vivanco, G.
    del Barco Morillo, E.
    Bernabe, R.
    Vinolas, N.
    Barneto Aranda, I. C.
    Massuti Sureda, B.
    Provencio, M.
    ANNALS OF ONCOLOGY, 2019, 30
  • [3] Neo-adjuvant chemo/immunotherapy for the treatment of resectable stage IIIA non-small cell lung cancer (NSCLC): A phase II multicenter exploratory study" NADIM trial
    Calvo de Juan, V.
    Insa Molla, A.
    Cobo Dols, M.
    Massuti Sureda, B.
    Lopez-Vivanco, G.
    Casal Rubio, J.
    de Castro, J.
    Majem Tarruella, M.
    Bernabe Caro, R.
    Gonzalez-Larriba, J.
    Barneto Aranda, I. C.
    Nadal, E.
    Martinez Marti, A.
    Vinolas Segarra, N.
    Guillot Morales, M.
    Vicente Baz, D.
    Camps Herrero, C.
    Domine Gomez, M.
    Rodriguez Abreu, D.
    Provencio Pulla, M.
    ANNALS OF ONCOLOGY, 2017, 28
  • [4] Adjuvant and neo-adjuvant immunotherapy in resectable non-small cell lung cancer (NSCLC): Current status and perspectives
    Xu, Ziyi
    Zou, Zihua
    Hao, Xuezhi
    Xing, Puyuan
    Li, Junling
    CANCER INNOVATION, 2023, 2 (01): : 65 - 78
  • [5] Feasibility of sleeve lobectomy after neo-adjuvant chemo-immunotherapy in non-small cell lung cancer
    Chen, Yulong
    Zhang, Lianmin
    Yan, Bo
    Zeng, Ziqing
    Hui, Zhenzhen
    Zhang, Ran
    Ren, Xiubao
    You, Jian
    TRANSLATIONAL LUNG CANCER RESEARCH, 2020, 9 (03) : 761 - 767
  • [6] TMB and Selected Mutations in Resectable Stage IIIA NSCLC Patients Receiving Neo-Adjuvant Chemo-Immunotherapy from NADIM Trial
    Cruz-Bermudez, A.
    Casarrubios, M.
    Briviesca, R. Laza
    Nadal, E.
    Insa, A.
    Mosquera, J.
    Huidobro, G.
    Domine Gomez, M.
    Massuti, B.
    Majem Tarruella, M.
    Rodriguez-Abreu, D.
    Martinez-Marti, A.
    De Castro Campeno, J.
    Cobo Dols, M.
    Lopez Vivanco, G.
    Del Barco, E.
    Bernabe Caro, R.
    Vinolas, N.
    Barneto, I.
    Viteri, S.
    Jove, M.
    Romero, A.
    Franco, F.
    Provencio, M.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S543 - S543
  • [7] Peripheral blood T-cell receptor immune repertoire characterization of resectable stage IIIA non-small cell lung cancer patients receiving neo-adjuvant chemo-immunotherapy treatment from NADIM study.
    Cruz Bermudez, Alberto
    Casarrubios, Marta
    Laza Briviesca, Raquel
    Sierra-Rodero, Belen
    Barquin, Miguel
    Romero, Atocha
    Franco, Fernando
    Calvo, Virginia
    Nadal, Ernest
    Insa, Amelia
    Garcia-Campelo, Rosario
    Casal, Joaquin
    Domine, Manuel
    Massuti, Bartomeu
    Majem, Margarita
    Rodriguez-Abreu, Delvys
    Martinez-Marti, Alex
    De Castro, Javier
    Provencio-Pulla, Mariano
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [8] Neo-adjuvant chemotherapy in non-small cell lung cancer (NSCLC)
    Santo, A.
    Genestreti, G.
    Sava, T.
    Manno, P.
    Terzi, A.
    Molino, A. M.
    Cetto, G. L.
    ANNALS OF ONCOLOGY, 2006, 17 : V55 - V61
  • [9] Phase II Study of Neo-Adjuvant Chemo/Immunotherapy for Resectable Stages IIIA Non-Small Cell Lung Cancer-Nadim Study-SLCG
    Provencio, M.
    Nadal, E.
    Insa, A.
    Campelo, R. Garcia
    Huidobro, G. G.
    Domine, M.
    Majem, M.
    Rodriguez-Abreu, D.
    Calvo, V.
    Martinez-Marti, A.
    De Castro, J.
    Cobo Dols, M.
    Lopez-Vivanco, G.
    Del Barco, E.
    Bernabe, R.
    Vinolas, N.
    Barneto, I.
    Massuti, B.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S320 - S320
  • [10] Phase III study of neo-adjuvant chemotherapy in resectable non-small cell lung cancer (NSCLC)
    Depierre, A
    Milleron, B
    Moro, D
    Quoix, E
    Lebeau, B
    Chastang, C
    Braun, D
    Janicot, H
    Paillot, N
    Gouva, S
    Coudert, B
    Breton, JL
    Lemarie, E
    Lebas, FX
    Coetmeur, D
    Thiberville, L
    Brehot, JM
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 1053 - 1053
12345